The value of certain assets isn’t set in stone: financial disasters, natural cata­strophes or extreme market fluc­tu­ations can lead to un­fore­seen economic damages. As soon as an impair­ment is noticed on one of your ac­count­able prop­er­ties, you should carry out an impair­ment test. This makes it possible to conduct an as­sess­ment of the capital assets, which is important for making a correct as­sess­ment of the company’s value.

What is impair­ment?

The term 'impair­ment' refers to the current value of an asset no longer cor­res­pond­ing to its balance sheet amount. This means that the in­form­a­tion disclosed in the balance sheet is no longer correct. The company would end up showing the assets as being too high or mis­rep­res­ent­ing their actual value. In principle, all assets and li­ab­il­it­ies on a balance sheet can be impaired (excluding con­struc­tion contracts). The impair­ment for all assets is regulated by the In­ter­na­tion­al Ac­count­ing Standard 36 (IAS 36). The only ex­cep­tions are values that are already regulated by other standards. These include, for example, in­vent­or­ies (IAS 2), con­struc­tion contacts (IAS 11), (an expected loss on a con­struc­tion contract should be re­cog­nised as an expense as soon as such loss is probable), and financial in­stru­ments (IAS 39). Most company purchases such as machines, vehicles, or IT equipment are generally subject to impair­ment due to wear and tear. As a result, scheduled de­pre­ci­ation is applied to these items: ac­count­ants regularly de­pre­ci­ate an asset from when it is purchased until when it is sold, lost, or scrapped. In addition, ac­count­ants also provide an un­sched­uled de­pre­ci­ation. This can occur both in the case of assets that are de­pre­ci­ated according to plan but are affected by an un­ex­pec­ted loss in value as well as in the case of valuables with an in­def­in­ite useful life. You can not write off the latter as planned. In either case, you must first perform an impair­ment test.

What is the purpose of an impair­ment test?

Impair­ment tests are regulated by the IFRS (In­ter­na­tion­al Financial Reporting Standards). These are mandatory lowest value tests and their purpose is to determine the actual value of assets. This makes it possible to make a reliable statement about a company’s current assets – this is par­tic­u­larly important for investors. Impair­ment tests are carried out in ac­cord­ance with IAS 36 whenever a suspected impair­ment exists. In­dic­a­tions can be internal as well as external. Internal in­dic­a­tions are, for example:

  • Aging
  • Physical damages
  • When the use of something is less valuable than before due to re­struc­tur­ing
  • Prof­it­ab­il­ity is lower than expected

External in­dic­a­tions include:

  • Declining market value
  • Poor economic and financial de­vel­op­ments
  • Increase in market interest rates
  • Falling stock exchange

In­tan­gible assets with an in­def­in­ite lifespan and those that are not yet ready for ap­plic­a­tion as well as goodwills must be tested each year for impair­ment. You can decide yourself when the testing should be carried out but once you’ve chosen a date, you must stick to it every year.

Fact

Four fifths of all companies schedule the ob­lig­at­ory impair­ment test for the balance sheet's deadline date.

Firstly, you determine the re­cov­er­able amount of the asset: this is either the net sale price or the value in use.

  • Net sales price: the number of sales generated by a company after the deduction of returns, al­low­ances for damaged or missing good and any discounts allowed. 
  • Value in use: present value of future cash flows expected to be generated through use.

The higher value out of the two de­term­ines the re­cov­er­able amount. This value is then compared with the carrying amount. The carrying amount is the value of an asset as reported in the balance sheet.

If the com­par­is­on shows that the carrying amount is above the re­cov­er­able amount, you have found an impair­ment. The con­sequence: a non-scheduled de­pre­ci­ation up to the value of the re­cov­er­able amount.

LVm1pt4tcqQ.jpg To display this video, third-party cookies are required. You can access and change your cookie settings here.

Goodwill impair­ment test: example invoice

When a company buys up another firm, it pays a purchase price. Before pur­chas­ing the buyer must calculate all of the assets (including any assumed debt) that the other company has. This value is likely to be below the purchase price. The dif­fer­ence between the two values is called goodwill. The buyer accepts the dif­fer­ence because they assume that the purchased resources can be used to make a profit. The purchase generates synergies through customer potential, market shares, or profit prospects that aren’t included in the assets. The buyer shows their 'good­will' during the price ne­go­ti­ation.

Note

In the case of goodwill, a dis­tinc­tion is made between the de­riv­at­ive and the original goodwill. The latter is generated by the company itself rather than through ac­quis­i­tions and shouldn’t be activated.

A case study example is the company, Albatros, who bought the company, Bravo, for $100 (£78) million. Financial experts from Albatros cal­cu­lated be­fore­hand that Bravo had an asset value of $60 (£47) million. This means that $40 (£31) million therefore counted as goodwill.

Goodwill appears as an asset in the balance sheet and therefore counts towards the company’s value. However, it is possible that goodwill could lose value within one year. Like certain other in­tan­gible assets, goodwill is subject to an annual impair­ment test. The value, however, does not have an iden­ti­fi­able cash flow and you cannot sell it. For this reason, a valuation level must be defined for the purpose of review, which is called a cash gen­er­at­ing unit (CGU). This is directly related to the goodwill and must be con­sist­ently selected from set­tle­ment period to set­tle­ment period (con­sist­ency rule). For example, the purchased company, or a de­part­ment in this company, can be defined as CGU.

Bravo was un­for­tu­nately not as suc­cess­ful as hoped. After one year, Albatros realised that the value in use was $70 (£55) million and the net sale price was $80 (£62) million. Compared to the carrying amount of $100 (£78) million ($80 (£62) million asset + $20 (£16) million goodwill), the re­cov­er­able amount was $80 (£62) million. Albartos recorded a goodwill impair­ment of $20 (£16) million.

Now the company has to write off the goodwill in order to adjust the balance to the actual value. In the case of Albatros and Bravo, the goodwill is 100%. If the goodwill is higher than the carrying amount, no ap­pre­ci­ation will occur. In this case, the carrying amount stays as it is.

Summary

Impair­ment tests are an important means of making sure a company’s balance sheet is as accurate as possible. Impair­ment test vi­ol­a­tions lead to errors on the balance sheet and, therefore, to a false eval­u­ation of the company.

Click here for important legal dis­claim­ers.

Reviewer

Go to Main Menu